3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Neoplasms
3
Prostatic Neoplasms
2
Urologic Neoplasms
1
Testicular Neoplasms
1
Sleep Initiation and Maintenance Disorders
1
Resectable Lung Non-Small Cell Carcinoma
1
Rectal Neoplasms
1
Penile Neoplasms
1
Pain
1
Neoplasm Metastasis
1
Motor Activity
1
Lymphedema
1
Low Anterior Resection Syndrome
1
Kidney Neoplasms
1
Glioma
1
Breast Neoplasms
1
Breast Cancer Lymphedema
1
Interventions
Magnetic Resonance Spectroscopy
56
enzalutamide
44
Specimen Handling
37
apalutamide
35
Androgen Antagonists
35
Abiraterone Acetate
29
Prednisone
27
Radiosurgery
26
darolutamide
25
Docetaxel
23
Pluvicto
22
abiraterone
21
Radiotherapy
21
Leuprolide
20
Biopsy
16
relugolix
14
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
14
gallium 68 PSMA-11
12
Triptorelin Pamoate
12
Surveys and Questionnaires
12
Radiation
12
Gonadotropin-Releasing Hormone
12
X-Rays
11
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
10
cabazitaxel
9
bicalutamide
9
Standard of Care
9
Nivolumab
9
Goserelin
9
Carboplatin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Physical Therapy Modalities
×
90 days
×
Clear all
NCT05946993
2026-05-01
LIAM Mc
University College Cork
Phase NA
Active not recruiting
72 enrolled
NCT06282185
2026-03-23
Superman
Canisius-Wilhelmina Hospital
Phase NA
Withdrawn